NCT05467527 PACT Programme for Parents of Children With SHCN
| NCT ID | NCT05467527 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Urologic Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 196 participants |
| Start Date | 2022-06-27 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 196 participants in total. It began in 2022-06-27 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomised controlled trial aims to determine the efficacy of a 12-week, smartphone-based Prosocial-orientated Acceptance and Commitment Training (PACT) programme plus age-appropriate positive parenting advice on the psychological flexibility, prosociality, parenting competence and family functioning with parents of children with special health care needs as well as the mental well-being of parent-child dyads over 12 months follow-up.
Eligibility Criteria
Inclusion Criteria: * Cantonese-speaking Hong Kong residents * Living together with the child who is at preschool/school-age (3-8 years old) * Caregivers who adopted the responsibility of taking care of the child, * has daily access to their iPhone and Android smartphones. In addition, potential eligible parents who respond "yes" to any of the five validated screening questions in the Children with Special Health Care Needs (SHCN) Screener (see https://www.childhealthdata.org/docs/cshcn/technical-summary-of-cshcn-screener.pdf) will then be asked the associated follow-up questions to determine whether the child possesses physical, neurodevelopmental/emotional problem(s) that has lasted for at least 12 months. Only children with a positive response(s) to ≥ 1 item in each of the associated follow-up questions will be classified as children with SHCN. Exclusion Criteria: * Parents who have diagnoses of severe mental illness or developmental disabilities, such as intellectual disabilities
Contact & Investigator
Yuen Yu Chong, PhD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT05467527 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Urologic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05467527 currently recruiting?
Yes, NCT05467527 is actively recruiting participants. Contact the research team at conniechong@cuhk.edu.hk for enrollment information.
Where is the NCT05467527 trial being conducted?
This trial is being conducted at Ngau Tau Kok, Hong Kong, Kowloon, Hong Kong.
Who is sponsoring the NCT05467527 clinical trial?
NCT05467527 is sponsored by Chinese University of Hong Kong. The principal investigator is Yuen Yu Chong, PhD at Chinese University of Hong Kong. The trial plans to enroll 196 participants.